Pyrotinib+Trastuzumab+Capecitabine: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

2

Conditions studied

0

US states with sites

1

Countries

Phase breakdown

Phase 2 1

Conditions being studied

Condition	Trials
Adjuvant Therapy	1
Breast Cancer	1

Recruiting trials involving Pyrotinib+Trastuzumab+Capecitabine

Compare Continuation of Original Targeted Therapy With Trastuzumab Combined With Pyrotinib and Capecitabine as Postoperative Adjuvant Therapy in Non-pCR Patients With HER2 Positive Early Breast Cancer
NCT05292742 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location

Common questions

How many recruiting trials involve Pyrotinib+Trastuzumab+Capecitabine?

1 recruiting trial across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.